Anand Kiran Parikh

Executive Officer, Director at Sensei Biotherapeutics.

Raised on Sensei Biotherapeutics filings

$348.9M

of $348.9M offered across 1 Form D filing

Form D filings: 1
Teammates: 6
Last filing: Mar 4, 2026

Company

Sensei Biotherapeutics

Biotech · Rockville, MD

Targeted drug for endometrial and breast cancer

Targeted drug for endometrial and breast cancer

Investors: 104

Investors: 104
Sector: Biotech
HQ: Rockville, MD

Sensei Biotherapeutics filings

Sensei Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 4, 2026	Equity	$348.9M/ $348.9M	Form D

EquityFiled Mar 4, 2026Form D
$348.9M/ $348.9M

Works with

Also named on Sensei Biotherapeutics filings

Christopher GerryPresident and Principal Executive Officer, Form D signerForm D signer Phillip DonenbergDirector Kristian HumerDirector Bob HolmenDirector Josiah CraverExecutive Officer Tom RicksDirector